ESH AL 2024 | Outcomes of ALL stratified by socioeconomic factors
Caner Saygin, MD, University of Chicago, Chicago, IL, discusses socioeconomic disparities impacting outcomes for patients with acute lymphoblastic leukemia (ALL). Patients of Hispanic or African American descent often experience inferior outcomes, likely attributed to care delivery rather than biological differences, as demonstrated in the comparable outcomes for Hispanic and White patients in the CALCG 10403 study (NCT00558519). Real-world data from a tertiary care center revealed that neither ethnicity nor income predicted outcomes. However, body mass index (BMI) emerged as a significant predictor, indicating poorer outcomes for patients classified as obese. This interview took place at the 4th European School of Hematology Acute Leukemia (ESH AL) congress in Stockholm, Sweden.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
